-
Je něco špatně v tomto záznamu ?
Validation of the REM sleep behavior disorder screening questionnaire in the Czech population
J. Bušková, P. Peřinová, E. Miletínová, P. Dušek, E. Růžička, K. Šonka, D. Kemlink,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, validační studie
Grantová podpora
16-28914A
Ministerstvo Zdravotnictví Ceské Republiky
16-07879S, project Nr. LO1611
Grantová Agentura České Republiky (CZ)
PROGRES Q35
Univerzita Karlova v Praze
PROGRES Q27/LF1
Univerzita Karlova v Praze
NV16-28914A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
BioMedCentral
od 2001-12-01
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-12-18
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- lidé středního věku MeSH
- lidé MeSH
- plošný screening metody MeSH
- porucha chování v REM spánku diagnóza MeSH
- překládání MeSH
- průzkumy a dotazníky * MeSH
- reprodukovatelnost výsledků MeSH
- senioři MeSH
- senzitivita a specificita MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- validační studie MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Idiopathic rapid eye movement sleep behavior disorder (iRBD) affects 1-2% of people over 60 years of age and presents a high risk of developing a neurodegenerative disorder from the group of synucleinopathies, such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Therefore, screening tools are needed. In 2007, the rapid eye movement sleep behavior disorder screening questionnaire (RBD-SQ) was developed and has been translated into several languages. The aim of study was to assess the validity and reliability of the Czech version of the RBD-SQ in a mixed population of sleep clinic patients, supplemented by healthy volunteers and RBD patients. METHODS: Participants included 81 iRBD patients, 205 patients with other sleep disorders (obstructive sleep apnea, insomnia, restless legs syndrome and periodic limb movement disorder, other parasomnias, or central hypersomnias including narcolepsy) and 20 healthy volunteers. RESULTS: The mean RBD-SQ score in the iRBD patients was 9.4 ± 2.8 points, and in the non-RBD group it was 4.5 ± 3.0 (P < 0.0001). Receiver -operator analysis yielded an area under the curve of 0.864, suggesting good diagnostic performance of the scale. When using a cut-off value for positivity of 5 points, sensitivity was 0.89 and specificity was 0.62. CONCLUSIONS: The Czech version of the RBD-SQ is a sensitive tool for screening for iRBD patients and helps to identify subjects for complete clinical workup.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034520
- 003
- CZ-PrNML
- 005
- 20191010121847.0
- 007
- ta
- 008
- 191007s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12883-019-1340-4 $2 doi
- 035 __
- $a (PubMed)31164104
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bušková, Jitka $u Department of Sleep Medicine, National Institute of Mental Health, Klecany, Czech Republic.
- 245 10
- $a Validation of the REM sleep behavior disorder screening questionnaire in the Czech population / $c J. Bušková, P. Peřinová, E. Miletínová, P. Dušek, E. Růžička, K. Šonka, D. Kemlink,
- 520 9_
- $a BACKGROUND: Idiopathic rapid eye movement sleep behavior disorder (iRBD) affects 1-2% of people over 60 years of age and presents a high risk of developing a neurodegenerative disorder from the group of synucleinopathies, such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Therefore, screening tools are needed. In 2007, the rapid eye movement sleep behavior disorder screening questionnaire (RBD-SQ) was developed and has been translated into several languages. The aim of study was to assess the validity and reliability of the Czech version of the RBD-SQ in a mixed population of sleep clinic patients, supplemented by healthy volunteers and RBD patients. METHODS: Participants included 81 iRBD patients, 205 patients with other sleep disorders (obstructive sleep apnea, insomnia, restless legs syndrome and periodic limb movement disorder, other parasomnias, or central hypersomnias including narcolepsy) and 20 healthy volunteers. RESULTS: The mean RBD-SQ score in the iRBD patients was 9.4 ± 2.8 points, and in the non-RBD group it was 4.5 ± 3.0 (P < 0.0001). Receiver -operator analysis yielded an area under the curve of 0.864, suggesting good diagnostic performance of the scale. When using a cut-off value for positivity of 5 points, sensitivity was 0.89 and specificity was 0.62. CONCLUSIONS: The Czech version of the RBD-SQ is a sensitive tool for screening for iRBD patients and helps to identify subjects for complete clinical workup.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a plošný screening $x metody $7 D008403
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a porucha chování v REM spánku $x diagnóza $7 D020187
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 12
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a překládání $7 D014175
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Peřinová, Pavla $u Department of Neurology and Center of Clinical Neurosciences, 1stFaculty of Medicine, Charles University, Kateřinská 30, 12000, Praha 2, Czech Republic.
- 700 1_
- $a Miletínová, Eva $u Department of Sleep Medicine, National Institute of Mental Health, Klecany, Czech Republic.
- 700 1_
- $a Dušek, Petr $u Department of Neurology and Center of Clinical Neurosciences, 1stFaculty of Medicine, Charles University, Kateřinská 30, 12000, Praha 2, Czech Republic.
- 700 1_
- $a Růžička, Evžen $u Department of Neurology and Center of Clinical Neurosciences, 1stFaculty of Medicine, Charles University, Kateřinská 30, 12000, Praha 2, Czech Republic.
- 700 1_
- $a Šonka, Karel $u Department of Neurology and Center of Clinical Neurosciences, 1stFaculty of Medicine, Charles University, Kateřinská 30, 12000, Praha 2, Czech Republic.
- 700 1_
- $a Kemlink, David $u Department of Neurology and Center of Clinical Neurosciences, 1stFaculty of Medicine, Charles University, Kateřinská 30, 12000, Praha 2, Czech Republic. david.kemlink@vfn.cz.
- 773 0_
- $w MED00008195 $t BMC neurology $x 1471-2377 $g Roč. 19, č. 1 (2019), s. 110
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31164104 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191010122305 $b ABA008
- 999 __
- $a ok $b bmc $g 1451180 $s 1073070
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 19 $c 1 $d 110 $e 20190604 $i 1471-2377 $m BMC neurology $n BMC Neurol $x MED00008195
- GRA __
- $a 16-28914A $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a 16-07879S, project Nr. LO1611 $p Grantová Agentura České Republiky (CZ)
- GRA __
- $a PROGRES Q35 $p Univerzita Karlova v Praze
- GRA __
- $a PROGRES Q27/LF1 $p Univerzita Karlova v Praze
- GRA __
- $a NV16-28914A $p MZ0
- LZP __
- $a Pubmed-20191007